Antibiotic-loaded tantalum may serve as an antimicrobial delivery agent.


Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
Jul 2019
Historique:
entrez: 2 7 2019
pubmed: 2 7 2019
medline: 10 7 2019
Statut: ppublish

Résumé

The aims of this study were to compare the mean duration of antibiotic release and the mean zone of inhibition between vancomycin-loaded porous tantalum cylinders and antibiotic-loaded bone cement at intervals, and to evaluate potential intrinsic antimicrobial properties of tantalum in an Ten porous tantalum cylinders and ten cylinders of cement were used. The tantalum cylinders were impregnated with vancomycin, which was also added during preparation of the cylinders of cement. The cylinders were then placed on agar plates inoculated with MSSA. The diameter of the inhibition zone was measured each day, and the cylinders were transferred to a new inoculated plate. Inhibition zones were measured with a Vernier caliper and using an automated computed evaluation, and the intra- and interobserver reproducibility were measured. The mean inhibition zones between the two groups were compared with Wilcoxon's test. MSSA was inhibited for 12 days by the tantalum cylinders and for nine days by the cement cylinders. At day one, the mean zone of inhibition was 28.6 mm for the tantalum and 19.8 mm for the cement group (p < 0.001). At day ten, the mean zone of inhibition was 3.8 mm for the tantalum and 0 mm for the cement group (p < 0.001). The porous tantalum cylinders soaked only with phosphate buffered solution showed no zone of inhibition. Compared with cement, tantalum could release antibiotics for longer. Further studies should assess the advantages of using antibiotic-loaded porous tantalum implants at revision arthroplasty. Cite this article:

Identifiants

pubmed: 31256673
doi: 10.1302/0301-620X.101B7.BJJ-2018-1206.R1
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bone Cements 0
Tantalum 6424HBN274
Vancomycin 6Q205EH1VU

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

848-851

Auteurs

P Sautet (P)

Institute for Locomotion, Center for Arthritis Surgery, Sainte-Marguerite Hospital, CNRS, Institute of Movement Sciences (ISM), Aix-Marseille University, Marseille, France.

S Parratte (S)

Institute for Locomotion, Center for Arthritis Surgery, Sainte-Marguerite Hospital, CNRS, Institute of Movement Sciences (ISM), Aix-Marseille University, Marseille, France.

T Mékidèche (T)

Department of Pharmacology and Toxicology, Timone Hospital, Aix-Marseille University, Marseille, France.

M P Abdel (MP)

Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.

X Flécher (X)

Institute for Locomotion, Center for Arthritis Surgery, Sainte-Marguerite Hospital, CNRS, Institute of Movement Sciences (ISM), Aix-Marseille University, Marseille, France.

J-N Argenson (JN)

Institute for Locomotion, Center for Arthritis Surgery, Sainte-Marguerite Hospital, CNRS, Institute of Movement Sciences (ISM), Aix-Marseille University, Marseille, France.

M Ollivier (M)

Institute for Locomotion, Center for Arthritis Surgery, Sainte-Marguerite Hospital, CNRS, Institute of Movement Sciences (ISM), Aix-Marseille University, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH